Multiple sclerosis, vitamin D, and HLA-DRB1*15

Neurology

Volumn 74, Issue 23, 2010, Pages 1905-1910

  Handunnetthi, Lahiru ^a   Ramagopalan, Sreeram V ^a   Ebers, George C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; HLA DR ANTIGEN; VITAMIN D;

GENE LOCUS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; RISK REDUCTION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; VITAMIN D;

EID: 77953354132     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e24124     Document Type: Review

References (60)

1. Garrod AE. The incidence of alkaptonuria: a study in chemical individuality: 1902 [classical article]. Yale J Biol Med 2002;75:221-231.
2. Scriver CR, Waters PJ. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet 1999;15: 267-272.
3. Despriet DD, Klaver CC, Witteman JC, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006;296: 301-309.
4. Lauer K. Ecologic studies of multiple sclerosis. Neurology 1997;49:S18-S26.
5. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables. Acta Psy-chiatr Scand Suppl 1960;35:132-147.
6. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-2838.
7. Dean G. Multiple sclerosis in migrants to South Africa. Isr J Med Sci 1971;7:1568.
8. Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, Mack TM. Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann Neurol 2006;60:56-64.
9. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005;330:120.
10. Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in U.S. veterans: 1: race, sex, and geographic distribution. Neurology 1979;29:1228-1235.
11. Ramagopalan SV, Ebers GC. Genes for multiple sclerosis. Lancet 2008;371:283-285.
12. Davenport C. Multiple sclerosis from the standpoint geographic distribution and race. Arch Neurol Psychiatry 1922;8:51-58.
13. Sutherland JM. Observations on the prevalence of multiple sclerosis in Northern Scotland. Brain 1956;79:635-654.
14. Poser CM. Viking voyages: the origin of multiple sclerosis? An essay in medical history. Acta Neurol Scand Suppl 1995;161:11-22.
15. Dunne C, McGuigan C, Crowley J, et al. Human leucocyte antigen class II polymorphism in Irish patients with multiple sclerosis. Tissue Antigens 2006;68:257-262.
16. Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995;58:2-6.
17. Swingler RJ, Compston D. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1986;49:1115-1124.
18. Vukusic S, Van Bockstael V, Gosselin S, Confavreux C. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry 2007; 78:707-709.
19. Bulman D, Ebers GC. The geography of MS reflects genetic susceptibility. J Trop Geogr Neurol 1992;2: 66-72.
20. Kimlin MG. Geographic location and vitamin D synthesis. Mol Aspects Med 2008;29:453-461.
21. Rigby WF, Waugh M, Graziano RF. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood 1990;76:189-197.
22. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009;5:e1000369.
23. Hensiek AE, Sawcer SJ, Feakes R, et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72:184-187.
24. Kragt J, van Amerongen B, Killestein J, et al. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009;15:9-15.
25. Chao MJ, Ramagopalan SV, Herrera BM, et al. Epigenet-ics in multiple sclerosis susceptibility: difference in trans-generational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009;18:261-266.
26. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr 2008;88:558S-564S.
27. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009;132: 1146-1160.
28. Smolders J, Thewissen M, Peelen E, et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009;4: e6635.
29. Tryon RC. Genetic differences in maze-learning ability in rats. Yearbook of the National Society for the Study of Education 1940;39:111-119.
30. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007;85:649-650.
31. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neu-rol 2006;5:932-936.
32. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009;41:824-828.
33. Torkildsen O, Knappskog PM, Nyland HI, Myhr KM. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Arch Neurol 2008;65:809-811.
34. Tajouri L, Ovcaric M, Curtain R, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 2005; 19:25-38.
35. Yeo TW, Maranian M, Singlehurst S, Gray J, Compston A, Sawcer S. Four single nucleotide polymorphisms from the vitamin D receptor gene in UK multiple sclerosis. J Neurol 2004;251:753-754.
36. Ponsonby AL, Pezic A, Ellis J, et al. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am J Epidemiol 2008;168:358-365.
37. Kurtzke JF. A reassessment of the distribution of multiple sclerosis: part one. Acta Neurol Scand 1975;51:110-136.
38. Miller DH, Hammond SR, McLeod JG, Purdie G, Skegg DC. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J Neurol Neu-rosurg Psychiatry 1990;53:903-905.
39. Hammond SR, English DR, McLeod JG. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 2000;123:968-974.
40. Sutherland JM, Tyrer JH, Eadie MJ. The prevalence of multiple sclerosis in Australia. Brain 1962;85:149-164.
41. van der Mei IA, Ponsonby AL, Blizzard L, Dwyer T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001;20:168-174.
42. Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 2000;57:418-421.
43. Westberg M, Feychting M, Jonsson F, Nise G, Gustavsson P. Occupational exposure to UV light and mortality from multiple sclerosis. Am J Ind Med 2009;52:353-357.
44. van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316.
45. Kampman MT, Wilsgaard T, Mellgren SI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007;254:471-477.
46. Islam T, Gauderman WJ, Cozen W, Mack TM. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 2007;69:381-388.
47. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62:60-65.
48. van der Mei IA, Ponsonby AL, Dwyer T, et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 2007;254:581-590.
49. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hup-perts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008;14:1220-1224.
50. Qin Z, Qin Y, Liu S. Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cell Mol Neuro-biol 2009;29:203-210.
51. Korn-Lubetzki I, Kahana E, Cooper G, Abramsky O. Activity of multiple sclerosis during pregnancy and puerpe-rium. Ann Neurol 1984;16:229-231.
52. Sotgiu S, Pugliatti M, Sotgiu MA, et al. Seasonal fluctuation of multiple sclerosis births in Sardinia. J Neurol 2006; 253:38-44.
53. Gardener H, Munger KL, Chitnis T, Michels KB, Spiegelman D, Ascherio A. Prenatal and perinatal factors and risk of multiple sclerosis. Epidemiology 2009;20:611-618.
54. Eyles D, Almeras L, Benech P, et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol 2007;103: 538-545.
55. Bahlo M, Booth DR, Broadley SA, et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41:824-828.
56. Cooper RM, Zubek JP. Effects of enriched and restricted early environments on the learning ability of bright and dull rats. Can J Psychol 1958;12:159-164.
57. Swank RL, Lerstad O, Strom A, Backer J. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med 1952;246: 722-728.
58. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008; 71:129-135.
59. Goldacre MJ, Seagroatt V, Yeates D, Acheson ED. Skin cancer in people with multiple sclerosis: a record linkage study. J Epidemiol Community Health 2004;58:142-144. (Pubitemid 38130483)
60. Tremlett H, van der Mei IA, Pittas F, et al. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 2008;31:271-279.